New genetic compound marker could help early diagnosis of aggressive prostate cancer
Tuesday, September 11, 2018 - 14:20
in Health & Medicine
A research team has discovered a link between the interplay of certain simultaneously occurring genetic changes in the HOXB13 and CIP2A genes, aggressiveness of prostate cancer, high risk of developing the disease, and poorer survival rates of patients. Prostate cancer is a major challenge in health care with over one million new cases and 300,000 deaths from it each year worldwide.